These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
284 related items for PubMed ID: 29752743
1. Therapy-related acute myeloid leukemia and myelodysplastic syndrome among refractory germ cell tumor patients. Inoue Y, Nakamura T, Nakanishi H, Oishi M, Hongo F, Okihara K, Mizutani S, Kuroda J, Ukimura O. Int J Urol; 2018 Jul; 25(7):678-683. PubMed ID: 29752743 [Abstract] [Full Text] [Related]
2. [A case of therapy-related leukemia/myelodysplastic syndrome following treatment of refractory testicular germ cell tumor]. Takizawa A, Miura T, Fujinami K, Osada Y, Tanaka M, Maruta I. Nihon Hinyokika Gakkai Zasshi; 2005 Nov; 96(7):701-4. PubMed ID: 16363657 [Abstract] [Full Text] [Related]
3. Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer. Wierecky J, Kollmannsberger C, Boehlke I, Kuczyk M, Schleicher J, Schleucher N, Metzner B, Kanz L, Hartmann JT, Bokemeyer C. J Cancer Res Clin Oncol; 2005 Apr; 131(4):255-60. PubMed ID: 15627215 [Abstract] [Full Text] [Related]
4. Secondary leukemia associated with a conventional dose of etoposide: review of serial germ cell tumor protocols. Nichols CR, Breeden ES, Loehrer PJ, Williams SD, Einhorn LH. J Natl Cancer Inst; 1993 Jan 06; 85(1):36-40. PubMed ID: 7677934 [Abstract] [Full Text] [Related]
5. Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy. Bajorin DF, Motzer RJ, Rodriguez E, Murphy B, Bosl GJ. J Natl Cancer Inst; 1993 Jan 06; 85(1):60-2. PubMed ID: 7677936 [No Abstract] [Full Text] [Related]
6. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group. Schmoll HJ, Kollmannsberger C, Metzner B, Hartmann JT, Schleucher N, Schöffski P, Schleicher J, Rick O, Beyer J, Hossfeld D, Kanz L, Berdel WE, Andreesen R, Bokemeyer C, German Testicular Cancer Study Group. J Clin Oncol; 2003 Nov 15; 21(22):4083-91. PubMed ID: 14568987 [Abstract] [Full Text] [Related]
7. Acute myelogenous leukemia after treatment for malignant germ cell tumors in children. Schneider DT, Hilgenfeld E, Schwabe D, Behnisch W, Zoubek A, Wessalowski R, Göbel U. J Clin Oncol; 1999 Oct 15; 17(10):3226-33. PubMed ID: 10506623 [Abstract] [Full Text] [Related]
8. The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors. Motzer RJ, Cooper K, Geller NL, Bajorin DF, Dmitrovsky E, Herr H, Morse M, Fair W, Sogani P, Russo P. Cancer; 1990 Dec 15; 66(12):2476-81. PubMed ID: 2174300 [Abstract] [Full Text] [Related]
9. Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors. Kollmannsberger C, Beyer J, Droz JP, Harstrick A, Hartmann JT, Biron P, Fléchon A, Schöffski P, Kuczyk M, Schmoll HJ, Kanz L, Bokemeyer C. J Clin Oncol; 1998 Oct 15; 16(10):3386-91. PubMed ID: 9779717 [Abstract] [Full Text] [Related]
10. High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA). Haugnes HS, Laurell A, Stierner U, Bremnes RM, Dahl O, Cavallin-Ståhl E, Cohn-Cedermark G. Acta Oncol; 2012 Feb 15; 51(2):168-76. PubMed ID: 22175254 [Abstract] [Full Text] [Related]
14. Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support. Broun ER, Nichols CR, Turns M, Williams SD, Loehrer PJ, Roth BJ, Lazarus HM, Einhorn LH. Cancer; 1994 Mar 15; 73(6):1716-20. PubMed ID: 7512438 [Abstract] [Full Text] [Related]
15. High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults. Lotz JP, André T, Donsimoni R, Firmin C, Bouleuc C, Bonnak H, Merad Z, Esteso A, Gerota J, Izrael V. Cancer; 1995 Feb 01; 75(3):874-85. PubMed ID: 7828139 [Abstract] [Full Text] [Related]
16. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors. Einhorn LH, Williams SD, Chamness A, Brames MJ, Perkins SM, Abonour R. N Engl J Med; 2007 Jul 26; 357(4):340-8. PubMed ID: 17652649 [Abstract] [Full Text] [Related]
17. [Salvage chemotherapy with paclitaxel, ifosphamide and nedaplatin for relapsed or refractory germ cell cancer]. Nomoto T, Mizutani Y, Mikami K, Nakamura T, Nakanishi H, Kawauchi A, Miki T. Nihon Hinyokika Gakkai Zasshi; 2006 May 26; 97(4):630-5. PubMed ID: 16768143 [Abstract] [Full Text] [Related]
18. Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study. Wessalowski R, Schneider DT, Mils O, Friemann V, Kyrillopoulou O, Schaper J, Matuschek C, Rothe K, Leuschner I, Willers R, Schönberger S, Göbel U, Calaminus G, MAKEI study group. Lancet Oncol; 2013 Aug 26; 14(9):843-52. PubMed ID: 23823158 [Abstract] [Full Text] [Related]